A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

Summary

The main purpose of this study is to evaluate the efficacy and safety in patients with advanced breast cancer treated with SYHX2011 versus paclitaxel for injection (albumin-bound).

Timeline

Start

2023-05-01

Primary completion

2024-09-01

Completion

2024-09-01

Publications

• Zhang L, Wang J, Sun T, Li F, Zhao B, Han G, Tong Z, Yang H, Yin Y, Kong X, Wang Y, Nie J, Ma L, Zhang Y, Luo J, Shan C, Yao J, Tan S, Ling X, Sun H, Li H, Ma L, Zhou T, Liu Y, Qi Y, Song Z, Li Y, Yang C, Hui T, Wang M, Wang H, Zhang X, Zhao W, Li Y, Li M, Xin Y, Luo X, Yin D, Luo H, Liu H, Lu Q, Yuan J, Zhang Q, Geng C. Albumin-Bound Paclitaxel (SYHX2011) in Patients with Advanced Breast Cancer: A Multicenter, Randomized, Double-Blind, Phase III Study. Cancer Commun (Lond). 2026 Jun 26;46:0037. doi: 10.34133/cancomm.0037. eCollection 2026.

Drugs

Indications